ClinicalTrials.gov · NCT05297019 · Unknown status
A Dosing Study of Hyperbaric Oxygen Therapy (HBOT) on Epigenetic Aging
Registry record
NCT05297019 on ClinicalTrials.gov. The registry's last update to this record was 12 April 2023.
Verification record
5 checked · 0 company says · 0 reported · 0 not found · 0 not yet checked
- Title as registered A Dosing Study of Hyperbaric Oxygen Therapy (HBOT) on Epigenetic Aging Checked Source clinicaltrials.gov Brief title as registered. Checked
- Sponsor TruDiagnostic Checked Source clinicaltrials.gov Lead sponsor as registered. Checked
- Intervention Hyperbaric Oxygen Therapy Checked Source clinicaltrials.gov Intervention names as registered. Checked
- Primary outcome as registered Epigenetic Aging Checked Source clinicaltrials.gov Primary outcome measure(s) as registered. Checked
- Status Unknown status Checked Source clinicaltrials.gov Overall status as registered; registry last update 2023-04-12. Checked
Check history: NCT05297019 was last read on the registry on November 14, 2026. No earlier checks are recorded. How records are checked.
Corrections: none recorded for this trial. To ask for one, write to [email protected] with the registry number; every correction is checked against the registry record before the record changes.
As registered
- Sponsor: TruDiagnostic
- Phase: Phase 2, Phase 3
- Status: Unknown status
- Intervention: Hyperbaric Oxygen Therapy
- Primary outcome: Epigenetic Aging
- Countries: United States
- Start: 1 March 2022
- Completion (estimated): 1 July 2023
Results
No results were posted on the registry on the date checked. The Atlas does not summarize findings.
Related modality